Annual Revenue
$1.20 M
+$1.06 M+766.19%
31 December 2023
Summary:
Lexicon Pharmaceuticals annual revenue is currently $1.20 million, with the most recent change of +$1.06 million (+766.19%) on 31 December 2023. During the last 3 years, it has fallen by -$22.79 million (-94.98%). LXRX annual revenue is now -99.63% below its all-time high of $322.07 million, reached on 31 December 2019.LXRX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$1.75 M
+$103.00 K+6.25%
30 September 2024
Summary:
Lexicon Pharmaceuticals quarterly revenue is currently $1.75 million, with the most recent change of +$103.00 thousand (+6.25%) on 30 September 2024. Over the past year, it has increased by +$1.59 million (+980.25%). LXRX quarterly revenue is now -99.41% below its all-time high of $294.45 million, reached on 30 September 2019.LXRX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$5.23 M
+$1.59 M+43.61%
30 September 2024
Summary:
Lexicon Pharmaceuticals TTM revenue is currently $5.23 million, with the most recent change of +$1.59 million (+43.61%) on 30 September 2024. Over the past year, it has increased by +$4.70 million (+884.75%). LXRX TTM revenue is now -98.42% below its all-time high of $330.42 million, reached on 30 September 2019.LXRX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LXRX Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +766.2% | +980.3% | +884.8% |
| 3 y3 years | -95.0% | +7508.7% | +982.6% |
| 5 y5 years | -98.1% | -99.4% | -98.4% |
LXRX Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -95.0% | +766.2% | at high | >+9999.0% | at high | +4697.3% |
| 5 y | 5 years | -99.6% | +766.2% | -99.4% | >+9999.0% | -98.4% | +4697.3% |
| alltime | all time | -99.6% | +766.2% | -99.4% | >+9999.0% | -98.4% | +4697.3% |
Lexicon Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.75 M(+6.3%) | $5.23 M(+43.6%) |
| June 2024 | - | $1.65 M(+45.8%) | $3.64 M(+57.6%) |
| Mar 2024 | - | $1.13 M(+61.0%) | $2.31 M(+91.8%) |
| Dec 2023 | $1.20 M(+766.2%) | $702.00 K(+333.3%) | $1.21 M(+126.9%) |
| Sept 2023 | - | $162.00 K(-48.9%) | $531.00 K(+30.1%) |
| June 2023 | - | $317.00 K(+1220.8%) | $408.00 K(+223.8%) |
| Mar 2023 | - | $24.00 K(-14.3%) | $126.00 K(-9.4%) |
| Dec 2022 | $139.00 K(-53.4%) | $28.00 K(-28.2%) | $139.00 K(+11.2%) |
| Sept 2022 | - | $39.00 K(+11.4%) | $125.00 K(+14.7%) |
| June 2022 | - | $35.00 K(-5.4%) | $109.00 K(-64.6%) |
| Mar 2022 | - | $37.00 K(+164.3%) | $308.00 K(+3.4%) |
| Dec 2021 | $298.00 K(-98.8%) | $14.00 K(-39.1%) | $298.00 K(-38.3%) |
| Sept 2021 | - | $23.00 K(-90.2%) | $483.00 K(-93.2%) |
| June 2021 | - | $234.00 K(+766.7%) | $7.09 M(-55.7%) |
| Mar 2021 | - | $27.00 K(-86.4%) | $16.02 M(-33.2%) |
| Dec 2020 | $24.00 M(-92.5%) | $199.00 K(-97.0%) | $24.00 M(-26.2%) |
| Sept 2020 | - | $6.63 M(-27.6%) | $32.52 M(-89.8%) |
| June 2020 | - | $9.16 M(+14.6%) | $320.34 M(-0.2%) |
| Mar 2020 | - | $8.00 M(-8.3%) | $320.86 M(-0.4%) |
| Dec 2019 | $322.07 M(+409.5%) | $8.73 M(-97.0%) | $322.07 M(-2.5%) |
| Sept 2019 | - | $294.45 M(+2941.2%) | $330.42 M(+669.6%) |
| June 2019 | - | $9.68 M(+5.1%) | $42.94 M(-8.7%) |
| Mar 2019 | - | $9.22 M(-46.0%) | $47.05 M(-25.6%) |
| Dec 2018 | $63.21 M(-31.1%) | $17.07 M(+145.1%) | $63.21 M(-21.5%) |
| Sept 2018 | - | $6.97 M(-49.5%) | $80.54 M(-19.9%) |
| June 2018 | - | $13.80 M(-45.6%) | $100.52 M(+1.8%) |
| Mar 2018 | - | $25.37 M(-26.2%) | $98.77 M(+7.7%) |
| Dec 2017 | $91.69 M(+15.7%) | $34.40 M(+27.7%) | $91.69 M(+20.3%) |
| Sept 2017 | - | $26.94 M(+123.5%) | $76.24 M(-1.0%) |
| June 2017 | - | $12.05 M(-34.1%) | $77.02 M(-9.4%) |
| Mar 2017 | - | $18.29 M(-3.5%) | $85.06 M(+7.3%) |
| Dec 2016 | $79.26 M(-39.0%) | $18.96 M(-31.6%) | $79.26 M(-57.7%) |
| Sept 2016 | - | $27.72 M(+38.0%) | $187.58 M(+16.9%) |
| June 2016 | - | $20.09 M(+60.8%) | $160.43 M(+14.0%) |
| Mar 2016 | - | $12.49 M(-90.2%) | $140.72 M(+8.2%) |
| Dec 2015 | $130.01 M(+468.9%) | $127.28 M(>+9900.0%) | $130.01 M(+436.9%) |
| Sept 2015 | - | $566.00 K(+50.5%) | $24.22 M(+0.6%) |
| June 2015 | - | $376.00 K(-79.0%) | $24.07 M(-1.2%) |
| Mar 2015 | - | $1.79 M(-91.7%) | $24.37 M(+6.6%) |
| Dec 2014 | $22.85 M(+928.5%) | $21.48 M(+5027.0%) | $22.85 M(+721.5%) |
| Sept 2014 | - | $419.00 K(-38.0%) | $2.78 M(+7.0%) |
| June 2014 | - | $676.00 K(+144.0%) | $2.60 M(+21.6%) |
| Mar 2014 | - | $277.00 K(-80.4%) | $2.14 M(-3.7%) |
| Dec 2013 | $2.22 M(+104.0%) | $1.41 M(+492.4%) | $2.22 M(+115.7%) |
| Sept 2013 | - | $238.00 K(+11.2%) | $1.03 M(-11.5%) |
| June 2013 | - | $214.00 K(-40.6%) | $1.16 M(+1.3%) |
| Mar 2013 | - | $360.00 K(+65.1%) | $1.15 M(+5.5%) |
| Dec 2012 | $1.09 M | $218.00 K(-41.4%) | $1.09 M(-10.3%) |
| Sept 2012 | - | $372.00 K(+86.9%) | $1.21 M(+1.4%) |
| June 2012 | - | $199.00 K(-33.7%) | $1.20 M(-22.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $300.00 K(-12.5%) | $1.55 M(-16.0%) |
| Dec 2011 | $1.85 M(-62.3%) | $343.00 K(-3.4%) | $1.85 M(-33.0%) |
| Sept 2011 | - | $355.00 K(-36.0%) | $2.76 M(-13.4%) |
| June 2011 | - | $555.00 K(-6.9%) | $3.19 M(-17.6%) |
| Mar 2011 | - | $596.00 K(-52.4%) | $3.86 M(-21.3%) |
| Dec 2010 | $4.91 M(-54.1%) | $1.25 M(+60.4%) | $4.91 M(-3.1%) |
| Sept 2010 | - | $781.00 K(-36.7%) | $5.07 M(-21.0%) |
| June 2010 | - | $1.23 M(-24.9%) | $6.42 M(-21.5%) |
| Mar 2010 | - | $1.64 M(+16.2%) | $8.17 M(-23.6%) |
| Dec 2009 | $10.70 M(-66.9%) | $1.41 M(-33.7%) | $10.70 M(-31.6%) |
| Sept 2009 | - | $2.13 M(-28.7%) | $15.64 M(-25.6%) |
| June 2009 | - | $2.99 M(-28.3%) | $21.02 M(-23.8%) |
| Mar 2009 | - | $4.17 M(-34.4%) | $27.60 M(-14.6%) |
| Dec 2008 | $32.32 M(-35.5%) | $6.35 M(-15.5%) | $32.32 M(-18.7%) |
| Sept 2008 | - | $7.51 M(-21.5%) | $39.78 M(-6.3%) |
| June 2008 | - | $9.57 M(+7.6%) | $42.43 M(-6.8%) |
| Mar 2008 | - | $8.89 M(-35.6%) | $45.52 M(-9.2%) |
| Dec 2007 | $50.12 M(-31.2%) | $13.81 M(+35.8%) | $50.12 M(-4.3%) |
| Sept 2007 | - | $10.17 M(-19.6%) | $52.38 M(-15.3%) |
| June 2007 | - | $12.65 M(-6.3%) | $61.82 M(-5.4%) |
| Mar 2007 | - | $13.49 M(-16.0%) | $65.34 M(-10.2%) |
| Dec 2006 | $72.80 M(-3.8%) | $16.07 M(-18.1%) | $72.80 M(-19.7%) |
| Sept 2006 | - | $19.61 M(+21.3%) | $90.63 M(+6.6%) |
| June 2006 | - | $16.16 M(-22.9%) | $84.98 M(+2.7%) |
| Mar 2006 | - | $20.95 M(-38.2%) | $82.71 M(+9.3%) |
| Dec 2005 | $75.68 M(+22.6%) | $33.89 M(+142.7%) | $75.68 M(+11.6%) |
| Sept 2005 | - | $13.96 M(+0.5%) | $67.80 M(+1.3%) |
| June 2005 | - | $13.90 M(-0.2%) | $66.94 M(+4.9%) |
| Mar 2005 | - | $13.93 M(-46.5%) | $63.82 M(+3.4%) |
| Dec 2004 | $61.74 M(+44.1%) | $26.01 M(+98.4%) | $61.74 M(+24.9%) |
| Sept 2004 | - | $13.11 M(+21.6%) | $49.43 M(+2.1%) |
| June 2004 | - | $10.78 M(-9.0%) | $48.43 M(+4.0%) |
| Mar 2004 | - | $11.84 M(-13.6%) | $46.57 M(+8.7%) |
| Dec 2003 | $42.84 M(+21.7%) | $13.70 M(+13.1%) | $42.84 M(+9.1%) |
| Sept 2003 | - | $12.11 M(+35.8%) | $39.26 M(+11.7%) |
| June 2003 | - | $8.92 M(+10.1%) | $35.16 M(-1.4%) |
| Mar 2003 | - | $8.11 M(-19.9%) | $35.65 M(+1.3%) |
| Dec 2002 | $35.20 M(+15.1%) | $10.12 M(+26.3%) | $35.20 M(-0.4%) |
| Sept 2002 | - | $8.01 M(-14.9%) | $35.35 M(-13.4%) |
| June 2002 | - | $9.41 M(+22.9%) | $40.83 M(+16.9%) |
| Mar 2002 | - | $7.66 M(-25.5%) | $34.92 M(+14.2%) |
| Dec 2001 | $30.58 M(+111.5%) | $10.27 M(-23.9%) | $30.58 M(+31.6%) |
| Sept 2001 | - | $13.49 M(+285.2%) | $23.23 M(+51.3%) |
| June 2001 | - | $3.50 M(+5.8%) | $15.35 M(+6.4%) |
| Mar 2001 | - | $3.31 M(+13.3%) | $14.43 M(-0.2%) |
| Dec 2000 | $14.46 M(+207.6%) | $2.92 M(-47.9%) | $14.46 M(+25.3%) |
| Sept 2000 | - | $5.61 M(+117.4%) | $11.54 M(+94.8%) |
| June 2000 | - | $2.58 M(-22.7%) | $5.92 M(+77.3%) |
| Mar 2000 | - | $3.34 M | $3.34 M |
| Dec 1999 | $4.70 M | - | - |
FAQ
- What is Lexicon Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals annual revenue year-on-year change?
- What is Lexicon Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals quarterly revenue year-on-year change?
- What is Lexicon Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals TTM revenue year-on-year change?
What is Lexicon Pharmaceuticals annual revenue?
The current annual revenue of LXRX is $1.20 M
What is the all time high annual revenue for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high annual revenue is $322.07 M
What is Lexicon Pharmaceuticals annual revenue year-on-year change?
Over the past year, LXRX annual revenue has changed by +$1.06 M (+766.19%)
What is Lexicon Pharmaceuticals quarterly revenue?
The current quarterly revenue of LXRX is $1.75 M
What is the all time high quarterly revenue for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high quarterly revenue is $294.45 M
What is Lexicon Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, LXRX quarterly revenue has changed by +$1.59 M (+980.25%)
What is Lexicon Pharmaceuticals TTM revenue?
The current TTM revenue of LXRX is $5.23 M
What is the all time high TTM revenue for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high TTM revenue is $330.42 M
What is Lexicon Pharmaceuticals TTM revenue year-on-year change?
Over the past year, LXRX TTM revenue has changed by +$4.70 M (+884.75%)